NEO-X-PRIME
Dead / Abandoned — Abandoned — failure to respond (as of 21 Apr 2025)
What this means for you
This application is over — abandoned 03 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79396585
- Mark type
- Stylized text
- Filed
- 14 Mar 2024
- Abandoned
- 03 Apr 2025
Goods and services
- Class 001 — Chemicals: Antibodies [for scientific and immuno-oncological use]; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds; none of the aforesaid goods being for use in newborn screening and invitro.
- Class 005 — Pharmaceuticals: Antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes; antibodies; none of the aforesaid goods being for use in newborn screening and invitro.
- Class 042 — Scientific and technological services: Bio-technology and scientific research services relating to antibodies, antibody formats, bispecific antibody formats, therapeutic antibodies, and immune-oncology preparations; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services; none of the aforesaid goods being for use in newborn screening and invitro.
Owner
Prosecution history
- 15 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Apr 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 21 Apr 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 19 Oct 2024 — REFUSAL PROCESSED BY IB
- 02 Oct 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 02 Oct 2024 — REFUSAL PROCESSED BY MPU
- 27 Sept 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 Sept 2024 — NON-FINAL ACTION WRITTEN
- 24 Sept 2024 — ASSIGNED TO EXAMINER
- 01 Jun 2024 — APPLICATION FILING RECEIPT MAILED
- 01 Jun 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 May 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB